Impact fact

Jennifer has used her payer-side experience to help develop global market access strategies for over 50 drug therapies.


Jennifer is a leader in ZS’s value and access practice. She has worked as a pharmaceutical strategy consultant in Europe and the U.S. and has extensive experience with market access issues in global markets. 




Jennifer helps clients optimize clinical development programs, shape corporate positioning and policy strategies in the evolving pricing environment, create strong payer value communication strategies, prepare for price negotiations, evaluate business development opportunities, and better integrate market access dynamics into their forecasting processes. Jennifer’s expertise spans a range of therapeutic areas, including cell and gene therapy, oncology, rare diseases, immunology, metabolic syndromes, cardiovascular and HIV. 



Prior experience

Jennifer is a former payer: She designed custom formularies and shaped public policy positioning at Aetna for several years.




Jennifer holds an M.Sc. in international healthcare management, economics and policy from SDA Bocconi School of Management in Milan, Italy, and a B.A. in biochemical sciences from Harvard University.